Practical insights for the clinical implementation of the EULAR recommendations for patients with systemic lupus erythematosus

13 core expert-driven advice points across four topics: setting standardised targets to modify disease course and prevent organ damage; taking action to achieve these targets; monitoring target achievement through validated clinical tools and frameworks; optimising therapeutic strategy to prevent flares and GC-associated toxicities

Includes scenarios for considering earlier biological and/or conventional immunosuppressive use, specific risk factors for poorer prognosis to inform treatment decisions, and suggestions on GC tapering